Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Return on Sales (2020 - 2023)

RAPT Therapeutics (RAPT) has disclosed Return on Sales for 4 consecutive years, with 109.01% as the latest value for Q1 2023.

  • Quarterly Return on Sales fell 7659.0% to 109.01% in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 109.01% through Mar 2023, down 8712.0% year-over-year, with the annual reading at 56.19% for FY2022, 3875.0% down from the prior year.
  • Return on Sales hit 109.01% in Q1 2023 for RAPT Therapeutics, down from 56.19% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 9.58% in Q3 2020 to a low of 109.01% in Q1 2023.
  • Historically, Return on Sales has averaged 28.23% across 4 years, with a median of 19.31% in 2021.
  • Biggest five-year swings in Return on Sales: surged 54bps in 2021 and later tumbled -7659bps in 2023.
  • Year by year, Return on Sales stood at 9.78% in 2020, then tumbled by -105bps to 20.09% in 2021, then plummeted by -180bps to 56.19% in 2022, then tumbled by -94bps to 109.01% in 2023.
  • Business Quant data shows Return on Sales for RAPT at 109.01% in Q1 2023, 56.19% in Q4 2022, and 33.53% in Q3 2022.